Sandoz: Well-Managed Generic Drug Producer, But Fairly Valued

2026-03-11 10:30:00 ET

Introduction

Last month, I moved Sandoz ( SDZNY ) to a ‘hold’ rating as the share price has performed exceptionally well in the past few quarters. The company has now published its full-year results which always is a good reason for an update. And perhaps even more important was the announcement earlier this week confirming Sandoz plans to take advantage of the expiring patents in the pharmaceutical sector. As one of the world’s largest companies in the generics and biosomilar medicine industry, Sandoz is in an excellent position to bring generic versions of medicine to the market. ...

Read the full article on Seeking Alpha

For further details see: